CO - Global Cord Blood Corporation

NYSE - NYSE Delayed Price. Currency in USD
6.32
-0.13 (-2.02%)
At close: 4:02PM EDT
Stock chart is not supported by your current browser
Previous Close6.45
Open6.39
Bid6.27 x 900
Ask6.33 x 1000
Day's Range6.14 - 6.48
52 Week Range5.67 - 10.12
Volume166,470
Avg. Volume41,815
Market Cap768.202M
Beta (3Y Monthly)0.31
PE Ratio (TTM)21.57
EPS (TTM)0.29
Earnings DateJun 19, 2019
Forward Dividend & Yield0.08 (1.25%)
Ex-Dividend Date2018-07-31
1y Target Est15.00
Trade prices are not sourced from all markets
  • PR Newswire5 days ago

    Global Cord Blood Corporation to Report Fourth Quarter and Full Year Fiscal 2019 Financial Results

    Earnings Call Scheduled for 8:00 a.m. ET on June 19, 2019 HONG KONG , June 11, 2019 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company") today announced that it plans to release ...

  • Markit6 days ago

    See what the IHS Markit Score report has to say about Global Cord Blood Corp.

    Global Cord Blood Corp NYSE:COView full report here! Summary * Bearish sentiment is low * Economic output for the sector is expanding but at a slower rate Bearish sentimentShort interest | PositiveShort interest is extremely low for CO with fewer than 1% of shares on loan. This could indicate that investors who seek to profit from falling equity prices are not currently targeting CO. Money flowETF/Index ownership | NeutralETF activity is neutral. The net inflows of $939,705 over the last one-month into ETFs that hold CO are not among the highest of the last year and have been slowing. Economic sentimentPMI by IHS Markit | NegativeAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however, and is easing. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to score@ihsmarkit.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.

  • PR Newswire10 days ago

    Global Cord Blood Corporation Announces Formation of a Special Committee to Evaluate Non-Binding Proposal

    HONG KONG, June 6, 2019 /PRNewswire/ -- Global Cord Blood Corporation (CO) (the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that in response to the non-binding proposal letter dated June 4, 2019 received by the Company's Board of Directors (the "Board") from Cordlife Group Limited ("Cordlife"), a company listed on the Mainboard of the Singapore Exchange Securities Trading Limited ("SGX"), pursuant to which Cordlife proposes to combine the businesses of Cordlife and the Company by way of a statutory merger, the Board has formed a special committee of independent directors who are not affiliated with Cordlife (the "Special Committee") to evaluate such proposal. The Special Committee consists of Mr. Mark D. Chen, Dr. Ken Lu and Ms. Jennifer J. Weng, each of whom currently serves as an independent director on the Board, with Mr. Chen serving as the chair of the Special Committee.

  • PR Newswire12 days ago

    Global Cord Blood Corporation Announces Receipt of Preliminary Non-Binding Proposal to Acquire the Company

    HONG KONG, June 4, 2019 /PRNewswire/ -- Global Cord Blood Corporation (CO) (the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that its board of directors has received a non-binding proposal letter from Cordlife Group Limited ("Cordlife"), a company listed on the Mainboard of the Singapore Exchange Securities Trading Limited ("SGX"), pursuant to which Cordlife proposes to combine the businesses of Cordlife and the Company, by way of a statutory merger.

  • ASICS And ASICS RUNKEEPER™ Celebrate The Love Of The Run For Global Running Day
    PR Newswire13 days ago

    ASICS And ASICS RUNKEEPER™ Celebrate The Love Of The Run For Global Running Day

    ASICS and ASICS RUNKEEPER community to share the ups (and downs) we've had with our shoes with #DearShoes social media giveaway, in-app run challenge and nearly 50 in-store events across the U.S. BOSTON, June 3, 2019 /PRNewswire/ -- ASICS, the true sport performance brand, and ASICS Runkeeper™ app are celebrating Global Running Day in the United States with a nationwide activation that gives runners and run lovers a platform to share why they love the pastime. With a deep history rooted in running, ASICS is at the core of many stories that describe the passion behind a run.

  • Here’s What Hedge Funds Think About Global Cord Blood Corporation (CO)
    Insider Monkeylast month

    Here’s What Hedge Funds Think About Global Cord Blood Corporation (CO)

    Hedge Funds and other institutional investors have just completed filing their 13Fs with the Securities and Exchange Commission, revealing their equity portfolios as of the end of December. At Insider Monkey, we follow nearly 750 active hedge funds and notable investors and by analyzing their 13F filings, we can determine the stocks that they are […]

  • PR Newswire2 months ago

    Global Cord Blood Corporation Raised Subscription Fee

    HONG KONG, April 1, 2019 /PRNewswire/ -- Global Cord Blood Corporation (CO) ("GCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced that the Company is increasing its processing fee by RMB3,000 to RMB9,800, effective on April 1, 2019. The Company's annual storage fee is unaffected by this increase. The Company is committed to delivering high quality and top of the line services to all clients, and this is evidenced by the Company's continuous investment in cord blood banking hardware as well as software.

  • Thomson Reuters StreetEvents4 months ago

    Edited Transcript of CO earnings conference call or presentation 26-Feb-19 1:00pm GMT

    Q3 2019 Global Cord Blood Corp Earnings Call

  • PR Newswire4 months ago

    Global Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2019

    3Q 19 Added 23,663 New Subscribers Revenues Up 3.7% YoY to RMB254.2 Million ( $37.0 Million )  Operating   Income Increased to RMB92.6 Million ( $13.5 Million ) Conference Call to be Held on February 26, ...

  • PR Newswire4 months ago

    Global Cord Blood Corporation to Report Third Quarter and First Nine Months Fiscal 2019 Financial Results

    Earnings Call Scheduled for 8:00 a.m. ET on February 26, 2019 HONG KONG , Feb. 19, 2019 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company"), China's leading provider of cord ...

  • Thomson Reuters StreetEvents5 months ago

    Edited Transcript of CO earnings conference call or presentation 28-Nov-18 1:00pm GMT

    Q2 2019 Global Cord Blood Corp Earnings Call